Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

BD Micro-Fine Ultra Pen Needle with Pentapoint technology launched in the UK and Ireland

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch in the UK and Ireland of BD Micro-Fine Ultra with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine+ Pen Needle.

From BD (Becton, Dickinson and Company) 27 Mar 2014

Expert highlights the importance of gender-specific approach for treating diabetes mellitus

The international guidelines on the drug-based therapy of diabetes mellitus specify which factors need to be taken into account during treatment.

27 Mar 2014

Researchers explore link between diet, metabolic homeostasis and air pollutant exposure

Is air pollution connected with increases in obesity, diabetes, and chronic kidney disease? Researchers are providing insight into that question today at the Society of Toxicology 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.

26 Mar 2014

New mathematical model predicts blood glucose levels with more than 90% accuracy

A mathematical model created by Penn State researchers can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance of imminent changes in their levels -- plenty of time to take preventative action.

26 Mar 2014

Study advises women to lose excess pregnancy weight in first year after delivery

'Watch out for weight gain within a year of giving birth to prevent new risk of diabetes and cardiovascular disease.' That advice for women comes from a study published today in the journal Diabetes Care.

26 Mar 2014

Antisense Therapeutics enrolls acromegalic patients in ATL1103 Phase II trial

Antisense Therapeutics Limited is pleased to report that 24 acromegalic patients have been successfully enrolled and randomized to one of the two treatment regimens of dosing in the Phase II trial of ATL1103 for the growth disorder, acromegaly. This satisfies the necessary patient numbers proposed for the trial.

24 Mar 2014

Bariatric surgery reduces uterine cancer risk by 71%

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center report that bariatric surgery resulting in dramatic weight loss in formerly severely obese women reduces the risk of endometrial (uterine) cancer by 71 percent and as much as 81 percent if normal weight is maintained after surgery.

24 Mar 2014

Up to a third of obese kids 'metabolically healthy'

Digits on a scale can help determine a child's weight, but their overall health status can be influenced by other factors such as physical activity, diet and screen time, according to new research from the University of Alberta and Alberta Health Services.

20 Mar 2014

Adocia announces positive final results for first clinical trial of BioChaperone Combo

Adocia announces today positive final results for the first clinical trial on its innovative formulation combining insulin analog glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.

20 Mar 2014

Insulin-secreting beta cells of pancreas have capacity to regenerate, say scientists

Vanderbilt University scientists have found evidence that the insulin-secreting beta cells of the pancreas, which are either killed or become dysfunctional in the two main forms of diabetes, have the capacity to regenerate.

20 Mar 2014

Scientists discover cellular pathway that may prevent onset of Type 2 diabetes

Scientists at the Children's Hospital of Eastern Ontario (CHEO) Research Institute have discovered a cellular pathway that is responsible for keeping blood sugar levels low in obese or pre-diabetic people, and may prevent the onset of Type 2 diabetes.

20 Mar 2014

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new data from Professor Isabelle Leclercq of Université Catholique de Louvain (Belgium) demonstrating the curative effects of GFT505 in an experimental model of NASH associated with metabolic disorders.

20 Mar 2014

Researchers discover potential new therapeutic target for controlling high blood sugar

A UT Southwestern Medical Center study has identified a new potential therapeutic target for controlling high blood sugar, a finding that could help the estimated 25 million Americans with type 2 diabetes.

19 Mar 2014

Chemical engineers design way to manufacture peptides in mere hours

Small protein fragments, also called peptides, are promising as drugs because they can be designed for very specific functions inside living cells. Insulin and the HIV drug Fuzeon are some of the earliest successful examples, and peptide drugs are expected to become a $25 billion market by 2018.

19 Mar 2014

Deer hunting science may help patients with diabetics, says study

Body odor is a deer hunter's worst enemy, an alert to animals that an ominous presence is lurking, but the science behind suppressing it to give hunters an edge oddly enough could help researchers develop a life-saving device for diabetes patients.

19 Mar 2014

Professor receives 2014 Rolf Luft Award for research on diabetes and endocrinology

Dr. Roger Unger, Professor of Internal Medicine at UT Southwestern Medical Center has been awarded the 2014 Rolf Luft Award for his identification of glucagon as a pancreatic hormone that raises blood sugar levels, having the opposite effect of insulin.

18 Mar 2014

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

The progressive form of Non-Alcoholic Fatty Liver Disease (NAFLD) is Non-Alcoholic Steatohepatitis (NASH), which defines a subgroup of NAFLD where liver steatosis co-exists with cell injury (hepatocyte ballooning) and inflammation with or without fibrosis at histological examination.

18 Mar 2014

Insulin News and Research

Further Reading

BD Micro-Fine Ultra Pen Needle with Pentapoint technology launched in the UK and Ireland

Expert highlights the importance of gender-specific approach for treating diabetes mellitus

Researchers explore link between diet, metabolic homeostasis and air pollutant exposure

New mathematical model predicts blood glucose levels with more than 90% accuracy

Study advises women to lose excess pregnancy weight in first year after delivery

Antisense Therapeutics enrolls acromegalic patients in ATL1103 Phase II trial

Bariatric surgery reduces uterine cancer risk by 71%

Up to a third of obese kids 'metabolically healthy'

Adocia announces positive final results for first clinical trial of BioChaperone Combo

Insulin-secreting beta cells of pancreas have capacity to regenerate, say scientists

Scientists discover cellular pathway that may prevent onset of Type 2 diabetes

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

Researchers discover potential new therapeutic target for controlling high blood sugar

Chemical engineers design way to manufacture peptides in mere hours

Deer hunting science may help patients with diabetics, says study

Professor receives 2014 Rolf Luft Award for research on diabetes and endocrinology

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

New sweetener from tequila plant may aid diabetes, weight loss

BDC to receive $2.1M grant to assist teens living with Type 1 diabetes

Gene linked with breast cancer susceptibility plays critical role in obesity and diabetes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News